201 related articles for article (PubMed ID: 28786142)
1. Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI.
Lampropoulos K; Megalou A; Bazoukis G; Tse G; Manolis A
J Interv Cardiol; 2017 Dec; 30(6):507-513. PubMed ID: 28786142
[TBL] [Abstract][Full Text] [Related]
2. Impact of statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Soud M; Ho G; Kuku KO; Hideo-Kajita A; Waksman R; Garcia-Garcia HM
Cardiovasc Revasc Med; 2018 Dec; 19(8):971-975. PubMed ID: 30056022
[TBL] [Abstract][Full Text] [Related]
3. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of complications after percutaneous coronary interventions with statins].
Mega S; Nusca A; Patti G
Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
[TBL] [Abstract][Full Text] [Related]
5. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
[TBL] [Abstract][Full Text] [Related]
7. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
Nusca A; Melfi R; Patti G; Sciascio GD
Future Cardiol; 2010 Sep; 6(5):579-89. PubMed ID: 20932108
[TBL] [Abstract][Full Text] [Related]
8. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
[TBL] [Abstract][Full Text] [Related]
9. Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Ndrepepa G; King L; Cassese S; Fusaro M; Tada T; Schömig A; Kastrati A
Eur J Intern Med; 2013 Mar; 24(2):145-50. PubMed ID: 23182629
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
Pan Y; Tan Y; Li B; Li X
Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
12. Statins and their role in pre-percutaneous coronary intervention.
Melfi R; Nusca A; Patti G; Di Sciascio G
Curr Cardiol Rep; 2010 Jul; 12(4):295-301. PubMed ID: 20440582
[TBL] [Abstract][Full Text] [Related]
13. Effect of statins therapy prior to percutaneous coronary intervention.
Luo J; Xu L; Yu T; Li J
J Interv Cardiol; 2012 Apr; 25(2):156-62. PubMed ID: 22248354
[TBL] [Abstract][Full Text] [Related]
14. Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies.
Xiao Y; He S; Zhang Z; Feng H; Cui S; Wu J
Med Sci Monit; 2018 Dec; 24():9166-9176. PubMed ID: 30557296
[TBL] [Abstract][Full Text] [Related]
15. Ample evidence for statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention.
Shariff M; Kumar U A
Cardiovasc Revasc Med; 2019 Jun; 20(6):533-534. PubMed ID: 31000432
[No Abstract] [Full Text] [Related]
16. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.
Patti G; Cannon CP; Murphy SA; Mega S; Pasceri V; Briguori C; Colombo A; Yun KH; Jeong MH; Kim JS; Choi D; Bozbas H; Kinoshita M; Fukuda K; Jia XW; Hara H; Cay S; Di Sciascio G
Circulation; 2011 Apr; 123(15):1622-32. PubMed ID: 21464051
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
[TBL] [Abstract][Full Text] [Related]
19. Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?
Athyros VG; Tziomalos K; Florentin M; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Apr; 26(4):839-42. PubMed ID: 20131958
[TBL] [Abstract][Full Text] [Related]
20. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
